Sign up to save your podcasts
Or
Share Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
CME credits: 0.50
Valid until: 10-04-2024
Claim your CME credit at https://reachmd.com/programs/cme/secondary-hyperparathyroidism-a-hidden-danger-in-chronic-kidney-disease/14973/
A high percentage of patients with chronic kidney disease have low levels of vitamin D leading to secondary hyperparathyroidism (SHPT), which plays a critical role in the development of chronic kidney disease-mineral and bone disorder (CKD-MBD). Our experts, Dr. Mario Cozzolino and Dr. Jan Kielstein, discuss the complexity of the condition, early diagnosis, treatment goals, and emerging therapies. Tune in to be sure you’re using all the tools at your disposal to improve your patients’ quality of life.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.50
Valid until: 10-04-2024
Claim your CME credit at https://reachmd.com/programs/cme/secondary-hyperparathyroidism-a-hidden-danger-in-chronic-kidney-disease/14973/
A high percentage of patients with chronic kidney disease have low levels of vitamin D leading to secondary hyperparathyroidism (SHPT), which plays a critical role in the development of chronic kidney disease-mineral and bone disorder (CKD-MBD). Our experts, Dr. Mario Cozzolino and Dr. Jan Kielstein, discuss the complexity of the condition, early diagnosis, treatment goals, and emerging therapies. Tune in to be sure you’re using all the tools at your disposal to improve your patients’ quality of life.
=